Bangkok, Thailand
NCT Number: NCT01030159
National Cancer Institute Thai Cancer Anemia Survey
The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemaglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with cancer
Exclusion criteria
- N/A
Treatment and study plan
Adult Cancer Patients
OtherTracking anemia management in Adult Cancer Patients
Primary outcomes
-
Number of patients that have anemia during cancer therapy
Time frame: 6 months
Secondary outcomes
-
Characteristics of patients example treatment duration, type of chemotherapy used, grade of anemia
Time frame: 6 months
Sponsors and collaborators
Lead sponsor
Janssen-Cilag Ltd.,Thailand
Industry
Registry information
Official study title
Anemia Survey in Cancer Patients Study
Important dates
- Study start
- 2006
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Dec 11, 2009
- Registry last updated
- Apr 9, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients
NCT06952361
Alternative Physiological Transfusion Triggers, Anemia
Almaty, Kazakhstan
View Trial DetailsTRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock
NCT03837171
Anemia, Cancer
Amiens, France
View Trial DetailsUse of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
NCT04246021
Anemia, Cancer
View Trial DetailsA Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer
NCT00153868
Anemia, Cancer
Lebanon, New Hampshire, United States
View Trial Details